| Literature DB >> 26573435 |
Jordi Díaz-Manera1, Aida Alejaldre2, Laura González3, Montse Olivé4, David Gómez-Andrés5, Nuria Muelas6, Juan José Vílchez6, Jaume Llauger7, Pilar Carbonell8, Celedonio Márquez-Infante8, Roberto Fernández-Torrón9, Juan José Poza10, Adolfo López de Munáin9, Lidia González-Quereda11, Sonia Mirabet12, Jordi Clarimon13, Pía Gallano14, Ricard Rojas-García2, Eduard Gallardo2, Isabel Illa2.
Abstract
Identifying the mutated gene that produces a particular muscle dystrophy is difficult because different genotypes may share a phenotype and vice versa. Muscle MRI is a useful tool to recognize patterns of muscle involvement in patients with muscle dystrophies and to guide the diagnosis process. The radiologic pattern of muscle involvement in patients with mutations in the EMD and LMNA genes has not been completely established. Our objective is to describe the pattern of muscle fatty infiltration in patients with mutations in the EMD and in the LMNA genes and to search for differences between the two genotypes that could be helpful to guide the genetic tests. We conducted a national multicenter study in 42 patients, 10 with mutations in the EMD gene and 32 with mutations in the LMNA gene. MRI or CT was used to study the muscles from trunk to legs. Patients had a similar pattern of fatty infiltration regardless of whether they had the mutation in the EMD or LMNA gene. The main muscles involved were the paravertebral, glutei, quadriceps, biceps, semitendinosus, semimembranosus, adductor major, soleus, and gastrocnemius. Involvement of peroneus muscle, which was more frequently affected in patients with mutations in the EMD gene, was useful to differentiate between the two genotypes. Muscle MRI/CT identifies a similar pattern of muscle fatty infiltration in patients with mutations in the EMD or the LMNA genes. The involvement of peroneus muscles could be useful to conduct genetic analysis in patients with an EDMD phenotype.Entities:
Keywords: EMD; Emery–Dreifuss; LMNA; Muscle CT; Muscle MRI; Muscle dystrophy
Mesh:
Substances:
Year: 2015 PMID: 26573435 DOI: 10.1016/j.nmd.2015.10.001
Source DB: PubMed Journal: Neuromuscul Disord ISSN: 0960-8966 Impact factor: 4.296